Shoichi Kanda

745 total citations
16 papers, 602 citations indexed

About

Shoichi Kanda is a scholar working on Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shoichi Kanda has authored 16 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Physiology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shoichi Kanda's work include Metabolism, Diabetes, and Cancer (6 papers), Adipose Tissue and Metabolism (5 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Shoichi Kanda is often cited by papers focused on Metabolism, Diabetes, and Cancer (6 papers), Adipose Tissue and Metabolism (5 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Shoichi Kanda collaborates with scholars based in Japan, United States and South Korea. Shoichi Kanda's co-authors include François R. Jornayvaz, Michael J. Jurczak, Varman T. Samuel, Gerald I. Shulman, Blas A. Guigni, Hui‐Young Lee, Kitt Falk Petersen, Dongyan Zhang, João Paulo Camporez and Andreas L. Birkenfeld and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Hepatology and The FASEB Journal.

In The Last Decade

Shoichi Kanda

16 papers receiving 596 citations

Peers

Shoichi Kanda
Vara Prasad Manchem United States
Céline Robichon France
K. Staiger Germany
Meric Erikci Ertunc United States
Alba Berlanga Spain
Shunxing Rong United States
Gabriela Suchánková United States
Kavita Jadhav United States
I.G. Safonova Russia
Eric R. Chen United States
Vara Prasad Manchem United States
Shoichi Kanda
Citations per year, relative to Shoichi Kanda Shoichi Kanda (= 1×) peers Vara Prasad Manchem

Countries citing papers authored by Shoichi Kanda

Since Specialization
Citations

This map shows the geographic impact of Shoichi Kanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoichi Kanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoichi Kanda more than expected).

Fields of papers citing papers by Shoichi Kanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoichi Kanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoichi Kanda. The network helps show where Shoichi Kanda may publish in the future.

Co-authorship network of co-authors of Shoichi Kanda

This figure shows the co-authorship network connecting the top 25 collaborators of Shoichi Kanda. A scholar is included among the top collaborators of Shoichi Kanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoichi Kanda. Shoichi Kanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Popov, Violeta, François R. Jornayvaz, Emin Özgür Akgül, et al.. (2015). Second‐generation antisense oligonucleotides against β‐catenin protect mice against diet‐induced hepatic steatosis and hepatic and peripheral insulin resistance. The FASEB Journal. 30(3). 1207–1217. 18 indexed citations
2.
Camporez, João Paulo, Shoichi Kanda, Max C. Petersen, et al.. (2014). ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content. Journal of Lipid Research. 56(3). 526–536. 49 indexed citations
3.
Lee, Hui‐Young, Arijeet K. Gattu, João Paulo Camporez, et al.. (2014). Muscle-specific activation of Ca2+/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice. Diabetologia. 57(6). 1232–1241. 16 indexed citations
4.
Ikeda, Mika, Asuka Naito, Masakazu Hirouchi, et al.. (2013). Arylpiperazines as fatty acid transport protein 1 (FATP1) inhibitors with improved potency and pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 23(9). 2560–2565. 21 indexed citations
5.
Camporez, João Paulo, François R. Jornayvaz, Hui‐Young Lee, et al.. (2013). Cellular Mechanism by Which Estradiol Protects Female Ovariectomized Mice From High-Fat Diet-Induced Hepatic and Muscle Insulin Resistance. Endocrinology. 154(3). 1021–1028. 157 indexed citations
6.
Ikeda, Mika, Asuka Naito, Masakazu Hirouchi, et al.. (2012). Discovery and optimization of novel fatty acid transport protein 1 (FATP1) inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(15). 5067–5070. 8 indexed citations
7.
Lee, Hui‐Young, Andreas L. Birkenfeld, François R. Jornayvaz, et al.. (2011). Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance. Hepatology. 54(5). 1650–1660. 111 indexed citations
8.
9.
Wakabayashi, Kenji, Yumi Matsui, Akihiro Furukawa, et al.. (2011). Pharmacology and in Vitro Profiling of a Novel Peroxisome Proliferator-Activated Receptor .GAMMA. Ligand, Cerco-A. Biological and Pharmaceutical Bulletin. 34(7). 1094–1104. 16 indexed citations
10.
Jornayvaz, François R., Andreas L. Birkenfeld, Michael J. Jurczak, et al.. (2011). Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2. Proceedings of the National Academy of Sciences. 108(14). 5748–5752. 132 indexed citations
11.
Okuno, Akira, Jun Tanaka, Kanako Takahashi, et al.. (2009). Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats. European Journal of Pharmacology. 623(1-3). 141–147. 24 indexed citations
12.
Kanda, Shoichi, Kanako Takahashi, Jun Tanaka, et al.. (2009). Potent Antidiabetic Effects of Rivoglitazone, a Novel Peroxisome Proliferator–Activated Receptor-γ Agonist, in Obese Diabetic Rodent Models. Journal of Pharmacological Sciences. 111(2). 155–166. 26 indexed citations
13.
Kanda, Shoichi, Satomi Adachi‐Akahane, & Taku Nagao. (1998). Functional interaction between benzothiazepine- and dihydropyridine binding sites of cardiac L-type Ca2+ channels. European Journal of Pharmacology. 358(3). 277–287. 7 indexed citations
14.
Kanda, Shoichi, Junko Kurokawa, Satomi Adachi‐Akahane, & Taku Nagao. (1997). Diltiazem derivatives modulate the dihydropyridine-binding to intact rat ventricular myocytes. European Journal of Pharmacology. 319(1). 101–107. 8 indexed citations
15.
Kanda, Shoichi, et al.. (1997). Functional allosteric interaction between diltiazem and dihydropyridlne sites of the cardiac L-type Ca2+ channel. The Japanese Journal of Pharmacology. 73. 82–82. 1 indexed citations
16.
Kanda, Shoichi, Junko Kurokawa, Satomi Adachi‐Akahane, & Taku Nagao. (1996). Effects of diltiazem derivatives on the specific binding of (+)-[3H]PN200-110 to isolated rat ventricular myocytes.. The Japanese Journal of Pharmacology. 71. 66–66. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vara Prasad Manchem Breakdown of academic impact, for papers by Céline Robichon Breakdown of academic impact, for papers by K. Staiger Breakdown of academic impact, for papers by Meric Erikci Ertunc Breakdown of academic impact, for papers by Alba Berlanga Breakdown of academic impact, for papers by Shunxing Rong Breakdown of academic impact, for papers by Gabriela Suchánková Breakdown of academic impact, for papers by Kavita Jadhav Breakdown of academic impact, for papers by I.G. Safonova Breakdown of academic impact, for papers by Eric R. Chen
Rankless by CCL
2026